Literature DB >> 3379973

Endogenous murine leukemia viruses: frequency of radiation-activation and novel pathogenic effects of viral isolates.

J Schmidt1, A Luz, V Erfle.   

Abstract

Female C57BL/6 and BALB/c mice were injected i.p. with 0.06 microCi/kg or 0.5 microCi/kg of the short-lived alpha-emitting radionuclide 224radium at 3-day intervals. Infectious N-ecotropic XC+, and xenotropic C-type retroviruses were activated in several tissues in both strains. In C57BL/6 mice the activation of ecotropic and xenotropic virus was dose-dependent as observed 4 weeks after the start of irradiation. In BALB/c mice a few animals showed activation of ecotropic virus after four weeks of irradiation. The expression of xenotropic virus was similar in irradiated mice and controls. Viral antigen, indicative for viraemia, was not detected in irradiated or control animals. Antiviral antibodies were found in both control and irradiated mice but higher titers were found in the irradiated mice. Bone tissue-derived N-tropic XC+ virus isolates were found to be non-oncogenic in newborn mice of the parental strain. In contrast, the same virus isolates induced a novel pattern of disease, such as osteopetrosis and osteomas together with malignant lymphomas in NMRI mice. The data indicate that the pattern of endogenous murine leukemia virus activation by internal alpha-irradiation is dependent on the dose rate, and on the genetics of the mouse strain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379973     DOI: 10.1016/0145-2126(88)90058-6

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

Review 1.  Bone tumor induction after incorporation of short-lived radionuclides.

Authors:  A Luz; W A Müller; U Linzner; P G Strauss; J Schmidt; K Müller; M J Atkinson; A B Murray; W Gössner; V Erfle
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

2.  Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response element.

Authors:  Ditte Ejegod; Karina Dalsgaard Sørensen; Ilona Mossbrugger; Leticia Quintanilla-Martinez; Jörg Schmidt; Finn Skou Pedersen
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

3.  Effects of leukemogenic retroviruses on condylar cartilage in vitro: an ultrastructural study.

Authors:  E Livne; J Schmidt; E I Closs; M Silbermann; V Erfle
Journal:  Calcif Tissue Int       Date:  1989-01       Impact factor: 4.333

4.  Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.

Authors:  Anne Ahlmann Nielsen; Annette Balle Sørensen; Jörg Schmidt; Finn Skou Pedersen
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Osteosarcomagenic doses of radium (224Ra) and infectious endogenous retroviruses enhance proliferation and osteogenic differentiation of skeletal tissue differentiating in vitro.

Authors:  J Schmidt; K Heermeier; U Linzner; A Luz; M Silbermann; E Livne; V Erfle
Journal:  Radiat Environ Biophys       Date:  1994       Impact factor: 1.925

6.  Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.

Authors:  A H Lund; J Schmidt; A Luz; A B Sørensen; M Duch; F S Pedersen
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Onset and dynamics of osteosclerosis in mice induced by Reilly-Finkel-Biskis (RFB) murine leukemia virus. Increase in bone mass precedes lymphomagenesis.

Authors:  J Schmidt; K Lumniczky; B D Tzschaschel; H L Guenther; A Luz; S Riemann; W Gimbel; V Erfle; R G Erben
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

8.  B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.

Authors:  J Lovmand; A B Sorensen; J Schmidt; M Ostergaard; A Luz; F S Pedersen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.

Authors:  Karina Dalsgaard Sørensen; Leticia Quintanilla-Martinez; Sandra Kunder; Jörg Schmidt; Finn Skou Pedersen
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

10.  Inactivation of p53 gene in human and murine osteosarcoma cells.

Authors:  N Chandar; B Billig; J McMaster; J Novak
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.